Memorial Sloan Kettering Cancer Center: clinical-trial pipeline
Memorial Sloan Kettering Cancer Center is the sponsor of 1,952 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 705 are not yet finished and 11 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Open trials705
Phase 2/3 and 373
Countries24
New in 90 days11
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 742 |
| Phase 2 | 647 |
| Phase 1 | 328 |
| Phase 1/2 | 116 |
| Phase 3 | 69 |
| Early phase 1 | 37 |
| Phase 4 | 9 |
| Phase 2/3 | 4 |
Trials by status
| Status | Trials |
|---|---|
| Completed | 1,133 |
| Active, not recruiting | 383 |
| Recruiting | 316 |
| Terminated | 69 |
| Withdrawn or not authorised | 43 |
| Not yet recruiting | 6 |
| Unknown | 2 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 1,733 |
| Nephrology and urology | 232 |
| Gastroenterology and liver | 144 |
| Women's health and obstetrics | 112 |
| Rare and genetic diseases | 67 |
| Dermatology | 57 |
| Metabolic and endocrine (diabetes, obesity) | 53 |
| Musculoskeletal | 48 |
| Haematology | 45 |
| Infectious disease and vaccines | 38 |
| Cardiovascular | 28 |
| Psychiatry and mental health | 17 |
Countries
| Country | Trials |
|---|---|
| United States | 1,927 |
| Canada | 18 |
| Nigeria | 5 |
| Australia | 3 |
| Spain | 3 |
| Israel | 3 |
| Italy | 3 |
| Netherlands | 3 |
| Puerto Rico | 3 |
| Germany | 2 |
| United Kingdom | 2 |
| Tanzania | 2 |
| Brazil | 1 |
| Czechia | 1 |
| Denmark | 1 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-22 | New trial posted | Using an Artificial Intelligence (AI) Tool for Melanoma Diagnosis |
| 2026-10-21 | New trial posted | A Study of Ropeg-Interferon in People With Polycythemia Vera |
| 2026-10-13 | New trial posted | A Study of Treatment Delivery Preference In People With Kidney Cancer |
| 2026-10-06 | New trial posted | Study of Vaping Use Among Adolescent and Young Adult Patients With Cancer |
| 2026-10-02 | New trial posted | Improving Goals of Care Conversations Between Doctors and Young Adults With Cancer |
| 2026-09-28 | New trial posted | A Study of Music Therapy for Anxiety in People With Cancer |
| 2026-09-21 | New trial posted | A Study of Ear Nerve Stimulation to Treat Eye Inflammation |
| 2026-09-14 | New trial posted | A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Aden… |
| 2026-09-11 | New trial posted | A Study of SX-682 in Combination With Proton Craniospinal Irradiation (pCSI) in People Wi… |
| 2026-09-03 | New trial posted | A Study of Stereotactic Radiosurgery (SRS) in People With Brain Cancer Having Tumor Resec… |
| 2026-09-02 | New trial posted | A Study of Zanubrutinib, Obinutuzumab, and Sonrotoclax in People With Mantle Cell Lymphoma |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT03574571 | A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer | Phase 3 | Active, not recruiting | Brazil, Spain, Netherlands, United States |
| NCT04891289 | Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With… | Phase 2 | Recruiting | Netherlands, United States |
| NCT07223021 | A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia | Phase 3 | Recruiting | Germany, Spain, Netherlands, United States |
| NCT05354570 | A Study of Intensity-Modulated Pleural Radiation Therapy (IMPRINT) in People With Thymic Cancer That Has Spre… | Phase 2 | Recruiting | United States |
| NCT06485778 | A Study of Radiation Therapy After Surgery in People With Oral Tongue Squamous Cell Carcinoma | Phase 2 | Recruiting | United States |
| NCT05239533 | Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney Cancer | Phase 2 | Active, not recruiting | United States |
| NCT00580385 | Chemotherapy Resistance in Osteogenic Sarcoma and Other Solid Tumors | Not applicable | Active, not recruiting | United States |
| NCT00579514 | Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients | Not applicable | Active, not recruiting | United States |
| NCT04332874 | A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma… | Phase 2 | Recruiting | United States |
| NCT03794635 | An Intervention to Help Patients and Caregivers Manage Stress and Improve Communication Skills When Talking A… | Not applicable | Active, not recruiting | United States |
| NCT06679829 | A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cel… | Phase 2 | Recruiting | United States |
| NCT06243757 | A Study of Minimally Invasive Proximal Gastrectomy Versus Minimally Invasive Total Gastrectomy for Gastric an… | Not applicable | Active, not recruiting | United States |
| NCT00492999 | Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treati… | Phase 2 | Active, not recruiting | United States |
| NCT05568420 | A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC) | Not applicable | Active, not recruiting | United States |
| NCT02375841 | Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers | Not applicable | Active, not recruiting | United States |
| NCT05884333 | Cord Blood Transplant in Adults With Blood Cancers | Phase 2 | Active, not recruiting | United States |
| NCT06814977 | An Acupuncture Study for Cancer Survivors With Joint Pain | Not applicable | Recruiting | United States |
| NCT04928677 | A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or… | Phase 1 | Recruiting | United States |
| NCT04872595 | A Modified Dose of Rabbit Anti-thymocyte Globulin (rATG) in Children and Adults Receiving Treatment to Help P… | Phase 2 | Active, not recruiting | United States |
| NCT03523377 | Overnight Fasting After Completion of Therapy: The OnFACT Study | Not applicable | Active, not recruiting | United States |
| NCT04180579 | Safety of Lower Scalp Cooling Temperature to Prevent Hair Loss From Chemotherapy in Breast Cancer Patients | Not applicable | Active, not recruiting | United States |
| NCT04107285 | Looking at Cognitive and Brain Changes in People With Lymphoma Receiving CAR-T Therapy | Not applicable | Recruiting | United States |
| NCT05203445 | A Study of Olaparib and Pembrolizumab in People With Triple Negative Breast Cancer (TNBC) or Hormone Receptor… | Phase 2 | Active, not recruiting | United States |
| NCT04555551 | MCARH109 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of Multiple Myeloma | Phase 1 | Active, not recruiting | United States |
| NCT06192888 | A Study of Glofitamab and Lenalidomide in People With Mantle Cell Lymphoma | Phase 1 | Active, not recruiting | United States |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Memorial Sloan Kettering Cancer Center clinical trials: 705 open, 73 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/memorial-sloan-kettering-cancer-center/, data as of 2026-10-25.